wehewehe pōkole:

ʻO 1.N,N-Dimethylformamide dimethyl acetal kahi mea hana no ka hana ʻana i nā derivatives pyridine inhibitory. Loaʻa i kēlā mau derivatives nā hopena inhibitory ma ka enzyme P13 kinase p110α.

2. Hoʻohana ʻia ma ke ʻano he waena no ka lāʻau lapaʻau zaleplon

3.Organic synthesis, pharmaceutical synthesis intermediate, precursor of formamidine synthesis. Hoʻomākaukau ʻana o 1,2,3-triketones a me indole, quinolone drug condensing agent. Hiki ke hoʻohana ʻia e synthesize ofloxacin, milrinone, allopurine a me nā lāʻau ʻē aʻe. Hoʻohana ʻia ma ke ʻano he intermediate no ka lāʻau lapaʻau zaleplon

4. Hoʻohana ʻia i nā ʻano hana hoʻonohonoho hou ʻana o Claisen othro-ester; hoʻohana ʻia i ka hoʻomākaukau ʻana o nā derivatives formamidine; hoʻopili catalytically i ka carbon dioxide a me nā hui epoxy ma lalo o nā kūlana solvent-free e synthesize i nā carbonates cyclic

Hoʻopili ʻana:
180kg/pahu, 25kg/pahu

Ka mālama ʻana:
Mālama ʻia i loko o kahi hale waihona anu a me ka ea maikaʻi, kahi kaʻawale mai ke ahi a me nā kumu wela.
Pono e mālama ʻokoʻa me nā mea oxidants, nā mea hoʻemi, nā waikawa, alkali, e pale i ka hoʻohuihui ʻana i ka mālama ʻana.